Walter Mauritz1, Ivan Janciak, Ingrid Wilbacher, Martin Rusnak. 1. Department of Anaesthesia and Critical Care Medicine, Trauma Hospital Lorenz Boehler, INRO (International Neurotrauma Research Organisation) Medical Advisory Board, Vienna, Austria. walter.mauritz@igeh.org
Abstract
OBJECTIVES: The goal of this paper is to describe the ICU management of severe traumatic brain injury (TBI) in Austria. PATIENTS AND METHODS: Data sets from 415 patients included by 5 Austrian hospitals were available. The analysis focused on complications and outcomes of intensive care, monitoring of intracranial pressure (ICP), efficacy of interventions to control ICP, management of hemodynamics and cerebral perfusion pressure (CPP), ventilation, and effects of hyperglycaemia. RESULTS: Overall ICU mortality was 30.8%; 90-day mortality was 35.7%. Final outcome was favorable in 33%, unfavorable in 51%, and in 16% the final outcome was unknown. An ICP monitoring device was used in 64%; most patients received intraparenchymal sensors (77%). Events associated with mortality > 50% were CPP < 50 mm Hg for > 12 hours/day, ICP > 25 mm Hg for > 12 hours/day, and MAP < 70 mm Hg for > 18 hours/day. The use of ICP monitoring was associated with significantly reduced ICU mortality. Interventions that may have improved the outcome included the use of barbiturates (short-term), hypertonic saline, moderate hyperventilation (33 < pCO2 < 37; p < 0.001 vs. aggressive hyper-and normoventilation), and normothermia. Hyperglycaemia was associated with poor outcome. CONCLUSIONS: Our study showed that ICU management of patients with severe TBI mostly follows international guidelines, and that outcome was comparable to or even better than that reported by other authors. Low CPP was associated with poor outcome, and was more often due to low MAP than to elevated ICP. The use of barbiturates and hypertonic saline was more common than expected. CPP should be maintained > 50 mm Hg, the use of catecholamines, fluid loading, barbiturates (short-term), moderate hyperventilation, hypertonic saline, and insulin may improve outcome after severe TBI.
OBJECTIVES: The goal of this paper is to describe the ICU management of severe traumatic brain injury (TBI) in Austria. PATIENTS AND METHODS: Data sets from 415 patients included by 5 Austrian hospitals were available. The analysis focused on complications and outcomes of intensive care, monitoring of intracranial pressure (ICP), efficacy of interventions to control ICP, management of hemodynamics and cerebral perfusion pressure (CPP), ventilation, and effects of hyperglycaemia. RESULTS: Overall ICU mortality was 30.8%; 90-day mortality was 35.7%. Final outcome was favorable in 33%, unfavorable in 51%, and in 16% the final outcome was unknown. An ICP monitoring device was used in 64%; most patients received intraparenchymal sensors (77%). Events associated with mortality > 50% were CPP < 50 mm Hg for > 12 hours/day, ICP > 25 mm Hg for > 12 hours/day, and MAP < 70 mm Hg for > 18 hours/day. The use of ICP monitoring was associated with significantly reduced ICU mortality. Interventions that may have improved the outcome included the use of barbiturates (short-term), hypertonicsaline, moderate hyperventilation (33 < pCO2 < 37; p < 0.001 vs. aggressive hyper-and normoventilation), and normothermia. Hyperglycaemia was associated with poor outcome. CONCLUSIONS: Our study showed that ICU management of patients with severe TBI mostly follows international guidelines, and that outcome was comparable to or even better than that reported by other authors. Low CPP was associated with poor outcome, and was more often due to low MAP than to elevated ICP. The use of barbiturates and hypertonicsaline was more common than expected. CPP should be maintained > 50 mm Hg, the use of catecholamines, fluid loading, barbiturates (short-term), moderate hyperventilation, hypertonicsaline, and insulin may improve outcome after severe TBI.
Authors: F Procaccio; N Stocchetti; G Citerio; M Berardino; L Beretta; F Della Corte; D D'Avella; G L Brambilla; R Delfini; F Servadei; G Tomei Journal: J Neurosurg Sci Date: 2000-03 Impact factor: 2.279
Authors: Kees H Polderman; Rudi Tjong Tjin Joe; Saskia M Peerdeman; William P Vandertop; Armand R J Girbes Journal: Intensive Care Med Date: 2002-10-04 Impact factor: 17.440
Authors: N Stocchetti; K I Penny; M Dearden; R Braakman; F Cohadon; F Iannotti; F Lapierre; A Karimi; A Maas; G D Murray; J Ohman; L Persson; F Servadei; G M Teasdale; T Trojanowski; A Unterberg Journal: Intensive Care Med Date: 2001-02 Impact factor: 17.440
Authors: D W Marion; L E Penrod; S F Kelsey; W D Obrist; P M Kochanek; A M Palmer; S R Wisniewski; S T DeKosky Journal: N Engl J Med Date: 1997-02-20 Impact factor: 91.245
Authors: Helmut Trimmel; Marek Majdan; Andrea Wodak; Guenther Herzer; Daniel Csomor; Alexandra Brazinova Journal: Wien Klin Wochenschr Date: 2017-07-27 Impact factor: 1.704
Authors: Walter Mauritz; Heinz Steltzer; Peter Bauer; Lorenz Dolanski-Aghamanoukjan; Philipp Metnitz Journal: Intensive Care Med Date: 2008-03-26 Impact factor: 17.440
Authors: David A Harrison; Kathryn A Griggs; Gita Prabhu; Manuel Gomes; Fiona E Lecky; Peter J A Hutchinson; David K Menon; Kathryn M Rowan Journal: J Neurotrauma Date: 2015-06-12 Impact factor: 5.269
Authors: J Leitgeb; W Mauritz; A Brazinova; M Majdan; I Janciak; I Wilbacher; M Rusnak Journal: Eur J Trauma Emerg Surg Date: 2013-03-05 Impact factor: 3.693